Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.

View in: PubMed

subject areas

Acute Disease
Adolescent
Adult
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Combined Chemotherapy Protocols
Disease-Free Survival
Female
Graft vs Host Disease
Humans
Leukemia, Myeloid
Male
Melphalan
Middle Aged
Myelodysplastic Syndromes
Proportional Hazards Models
Prospective Studies
Remission Induction
Stem Cell Transplantation
Transplantation Conditioning
Vidarabine

authors with profiles

Michael J. Thirman
Richard A. Larson
Amittha Wickrema
Lucy Godley
Olatoyosi Odenike
Christopher Daugherty
Wendy Stock
Koen Van Besien